missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Mouse BAFF/BLyS/TNFSF13B Protein
Description
The Recombinant Mouse BAFF/BLyS/TNFSF13B Protein is derived from NS0. The Recombinant Mouse BAFF/BLyS/TNFSF13B Protein has been validated for the following applications: Bioactivity.
Specifications
Specifications
| Accession Number | Q9WU72 |
| For Use With (Application) | Bioactivity |
| Gene ID (Entrez) | 10673 |
| Molecular Weight (g/mol) | Observed M.W.: 19-23kDa, reducing conditions, Theoretical M.W.: 21kDa |
| Quantity | 10 μg |
| Source | Mouse myeloma cell line,NS0-derived mouse BAFF/BLyS/TNFSF13B protein Ala127-Leu309 |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU per 1μg of the protein by the LAL method. |
| Gene Alias | ApoL related ligand TALL-1, B lymphocyte stimulator, BAFFB-cell activating factor, B-cell-activating factor, BLyS, BLYSB-lymphocyte stimulator, CD257, CD257 antigen, Dendritic cell-derived TNF-like molecule, DTL, TALL1, TALL-1delta BAFF, TALL1Delta4 BAFF, THANK, TNF and ApoL-related leukocyte expressed ligand 1, TNF- and APOL-related leukocyte expressed ligand 1, TNF homolog that activates apoptosis, TNFSF13B, TNFSF20, tumor necrosis factor (ligand) superfamily, member 13b, tumor necrosis factor (ligand) superfamily, member 20, tumor necrosis factor ligand superfamily member 13B, tumor necrosis factor superfamily, member 13b, tumor necrosis factor-like protein ZTNF4, ZTNF4 |
| Common Name | BAFF/BLyS/TNFSF13B |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?